[The influence of body mass reduction on metabolic disorders and complications in patient with morbid obesity. Three years observation].
We describe a case of 40-year-old male with giant obesity, with signs of metabolic syndrome, treated with low-calorie diet (700 kcal in 1-st year of treatment, 1200 kcal in 2-nd and 3-rd year of treatment), and supplementary pharmacotherapy with sibutramine. Patient initial weight was 170,9 kg, height 189 cm, BMI = 47,8 kg/m2. In summary weight loss in this patient was 52,9 kg, this is 30,9% of initial value. This case report shows that giant obesity with accompanying metabolic disorders and complications can be treated with combination of diet, physical activity and pharmacotherapy. The key factor of successful therapy is personal motivation of a patient.
Pietrzak-Nowacka
Maria
M
Klinika Nefrologii, Transplantologii i Chorób Wewnetrznych PAM w Szczecinie.
Safranow
Krzysztof
K
Kedzierska
Karolina
K
D000328:Adult; D001067:Appetite Depressants / Q000627:therapeutic use; D015992:Body Mass Index; D004038:Diet, Reducing; D015444:Exercise; D006801:Humans; D008297:Male; D024821:Metabolic Syndrome / Q000209:etiology / Q000517:prevention & control*; D009765:Obesity / Q000150:complications* / Q000178:diet therapy / Q000188:drug therapy / Q000628:therapy*; D016896:Treatment Outcome; D015431:Weight Loss
D001067:Appetite Depressants